Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.

ABSTRACT:

Background

The selection of patients for resective therapy of hepatic colorectal metastases remains controversial. A number of clinical and pathologic prognostic risk factors have been variably reported to influence survival.

Methods

Between January 1981 and December 1991, 204 patients underwent curative hepatic resection for metastatic colorectal cancer. Fourteen clinical and pathologic determinants previously reported to influence outcome were examined retrospectively. This led to a proposed TNM staging system for metastatic colorectal cancer (mTNM).

Results

No operative deaths occurred (death within 1 month). Overall 1-, 3-, and 5-year survivals were 91%, 43%, and 32%, respectively. Gender, Dukes' classification, site of primary colorectal cancer, histologic differ

SUBMITTER: Gayowski TJ 

PROVIDER: S-EPMC2967179 | biostudies-literature | 1994 Oct

REPOSITORIES: biostudies-literature